Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 2/2016

19.04.2016 | Original Research

The Herbal Medicine Utrica Dioica Inhibits Proliferation of Colorectal Cancer Cell Line by Inducing Apoptosis and Arrest at the G2/M Phase

verfasst von: Ali Mohammadi, Behzad Mansoori, Mahyar Aghapour, Pooneh Chokhachi Baradaran, Neda Shajari, Sadaf Davudian, Shima Salehi, Behzad Baradaran

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

One of the major causes of cancer death internationally and the third most prevalent cancer in the world has been diagnosed with colorectal cancer. Although current routine treatments of cancer have been successful in some extent, mortality caused by adverse effects of these strategies is still raising. Medicinal plants are potential sources of anticancer compounds and can be exploited as a powerful complementary tool. This study aimed to investigate the cytotoxic effects of nettle extract on mouse colorectal cancer cells, HCT.

Materials and Methods

In the present study, to evaluate the cytotoxicity of nettle extract, MTT assay and trypan blue were performed. Subsequently, DNA fragmentation and TUNEL test was carried out for determination of apoptosis. Real-time PCR test was used to quantify the expression of Caspase-3, Caspase-9, and Bcl-2 which is involved in apoptosis regulation. Finally, cell cycle analysis was conducted by using flow cytometry.

Results

The results of MTT assay showed that the dichloromethane extract of U. dioica extract significantly destroyed cancer cells HCT-116. DNA fragmentation and TUNEL test demonstrated that Utrica extract elicited apoptotic response in the cancer cells. The messenger RNA (mRNA) expression levels of Caspase-3 and Caspase-9 markedly increased, while the Bcl-2 gene was conversely downregulated. Findings of flow cytometry confirmed that cell cycle arrest has occurred at the G2 phase.

Conclusion

Taken together, our experiment showed that subjecting HCT-116 cells to dichloromethane extract of nettle (U. dioica), increases turnover of these cells. Thus, it may be a useful agent in the treatment of colorectal cancer.
Literatur
1.
Zurück zum Zitat Medina-Ramirez CM, Goswami S, Smirnova T, Bamira D, Benson B, Ferrick N, et al. Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance. Cancer Res. 2011;71(24):7705–15.CrossRefPubMedPubMedCentral Medina-Ramirez CM, Goswami S, Smirnova T, Bamira D, Benson B, Ferrick N, et al. Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance. Cancer Res. 2011;71(24):7705–15.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Bhalla KN, Rao R, Sharma P, Das Gupta S, Chauhan L, Stecklein S, et al. Treatment with histone deacetylase inhibitors creates ‘BRCAness’ and sensitizes human triple negative breast cancer cells to PARP inhibitors and cisplatin. Cancer Res. 2012;72(24 Supplement):S3–7.CrossRef Bhalla KN, Rao R, Sharma P, Das Gupta S, Chauhan L, Stecklein S, et al. Treatment with histone deacetylase inhibitors creates ‘BRCAness’ and sensitizes human triple negative breast cancer cells to PARP inhibitors and cisplatin. Cancer Res. 2012;72(24 Supplement):S3–7.CrossRef
4.
Zurück zum Zitat Zhang Y, Peng L, Mumper RJ, Huang L. Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. Biomaterials. 2013;34(33):8459–68.CrossRefPubMedPubMedCentral Zhang Y, Peng L, Mumper RJ, Huang L. Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. Biomaterials. 2013;34(33):8459–68.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.CrossRefPubMed Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.CrossRefPubMed
8.
Zurück zum Zitat Robak T, Wierzbowska A. Current and emerging therapies for acute myeloid leukemia. Clin Ther. 2009;31:2349–70.CrossRefPubMed Robak T, Wierzbowska A. Current and emerging therapies for acute myeloid leukemia. Clin Ther. 2009;31:2349–70.CrossRefPubMed
9.
Zurück zum Zitat Kupsa T, Milos Horacek J, Jebavy L. The role of cytokines in acute myeloid leukemia: a systematic review. Biomed Pap. 2012;156(4):291–301. Kupsa T, Milos Horacek J, Jebavy L. The role of cytokines in acute myeloid leukemia: a systematic review. Biomed Pap. 2012;156(4):291–301.
10.
Zurück zum Zitat Arpinati M, Curti A. Immunotherapy in acute myeloid leukemia. Immunotherapy. 2014;6(1):95–106.CrossRefPubMed Arpinati M, Curti A. Immunotherapy in acute myeloid leukemia. Immunotherapy. 2014;6(1):95–106.CrossRefPubMed
12.
Zurück zum Zitat Saha D, Roman C, Beauchamp RD. New strategies for colorectal cancer prevention and treatment. World J Surg. 2002;26(7):762–6.CrossRefPubMed Saha D, Roman C, Beauchamp RD. New strategies for colorectal cancer prevention and treatment. World J Surg. 2002;26(7):762–6.CrossRefPubMed
13.
Zurück zum Zitat Fleshner P, Slater G, Aufses Jr AH. Age and sex distribution of patients with colorectal cancer. Dis Colon Rectum. 1989;32(2):107–11.CrossRefPubMed Fleshner P, Slater G, Aufses Jr AH. Age and sex distribution of patients with colorectal cancer. Dis Colon Rectum. 1989;32(2):107–11.CrossRefPubMed
14.
Zurück zum Zitat Chattar-Cora D, Onime GD, Valentine IS, Cudjoe E, Rivera L. Colorectal cancer in a multi-ethnic urban group: its anatomical and age profile. Int Surg. 1999;85(2):137–42. Chattar-Cora D, Onime GD, Valentine IS, Cudjoe E, Rivera L. Colorectal cancer in a multi-ethnic urban group: its anatomical and age profile. Int Surg. 1999;85(2):137–42.
15.
Zurück zum Zitat Mansoori B, Shotorbani SS, Baradaran B. RNA interference and its role in cancer therapy. Adv Pharm Bull. 2014;4(4):313.PubMedPubMedCentral Mansoori B, Shotorbani SS, Baradaran B. RNA interference and its role in cancer therapy. Adv Pharm Bull. 2014;4(4):313.PubMedPubMedCentral
16.
Zurück zum Zitat Mansoori B, Mohammadi A, Shir Jang S, Baradaran B. Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA). Artif Cells Nanomed Biotechnol. 2015;26:1–8.CrossRef Mansoori B, Mohammadi A, Shir Jang S, Baradaran B. Mechanisms of immune system activation in mammalians by small interfering RNA (siRNA). Artif Cells Nanomed Biotechnol. 2015;26:1–8.CrossRef
17.
Zurück zum Zitat Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res. 2006;12(1):11–9.CrossRefPubMed Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, et al. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res. 2006;12(1):11–9.CrossRefPubMed
18.
Zurück zum Zitat HemaIswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res. 2006;20(4):239–49.CrossRefPubMed HemaIswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res. 2006;20(4):239–49.CrossRefPubMed
19.
Zurück zum Zitat H W KG. Virginia native plants. Virginia: Black Cat Press; 2005. H W KG. Virginia native plants. Virginia: Black Cat Press; 2005.
20.
Zurück zum Zitat Mohammadi A, Mansoori B, Goldar S, Shanehbandi D, Khaze V, Mohammadnejad L, et al. Effects of Urtica dioica dichloromethane extract on cell apoptosis and related gene expression in human breast cancer cell line (MDA-MB-468). Cell Mol Biol. 2016;62(2):62. Noisy-le-Grand, France.PubMed Mohammadi A, Mansoori B, Goldar S, Shanehbandi D, Khaze V, Mohammadnejad L, et al. Effects of Urtica dioica dichloromethane extract on cell apoptosis and related gene expression in human breast cancer cell line (MDA-MB-468). Cell Mol Biol. 2016;62(2):62. Noisy-le-Grand, France.PubMed
21.
Zurück zum Zitat Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Med Res Rev. 2003;23(4):519–34.CrossRefPubMed Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Med Res Rev. 2003;23(4):519–34.CrossRefPubMed
22.
Zurück zum Zitat Sylvester PW, Shah S. Antioxidants in dietary oils: their potential role in breast cancer prevention. Malays J Nutr. 2002;8:1–11.PubMed Sylvester PW, Shah S. Antioxidants in dietary oils: their potential role in breast cancer prevention. Malays J Nutr. 2002;8:1–11.PubMed
23.
Zurück zum Zitat Baumeister P, Reiter M, Harréus U. Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention. Oxidative Med Cell Longev. 2012;2012:902716.CrossRef Baumeister P, Reiter M, Harréus U. Curcumin and other polyphenolic compounds in head and neck cancer chemoprevention. Oxidative Med Cell Longev. 2012;2012:902716.CrossRef
24.
Zurück zum Zitat Chabner BA, Friedman MA. Progress against rare and not-so-rare cancers. N Engl J Med. 1992;326(8):563–5.CrossRefPubMed Chabner BA, Friedman MA. Progress against rare and not-so-rare cancers. N Engl J Med. 1992;326(8):563–5.CrossRefPubMed
25.
Zurück zum Zitat Ait-Mohamed O, Battisti V, Joliot V, Fritsch L, Pontis J, Medjkane S, et al. Acetonic extract of buxus sempervirens induces cell cycle arrest, apoptosis and autophagy in breast cancer cells. PLoS ONE. 2011;6(9):e24537.CrossRefPubMedPubMedCentral Ait-Mohamed O, Battisti V, Joliot V, Fritsch L, Pontis J, Medjkane S, et al. Acetonic extract of buxus sempervirens induces cell cycle arrest, apoptosis and autophagy in breast cancer cells. PLoS ONE. 2011;6(9):e24537.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Gözüm S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs. 2003;26(3):230–6.CrossRefPubMed Gözüm S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs. 2003;26(3):230–6.CrossRefPubMed
27.
Zurück zum Zitat Konrad L, Müller H-H, Lenz C, Laubinger H, Aumüller G, Lichius JJ. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med. 2000;66(1):44–7.CrossRefPubMed Konrad L, Müller H-H, Lenz C, Laubinger H, Aumüller G, Lichius JJ. Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract. Planta Med. 2000;66(1):44–7.CrossRefPubMed
28.
Zurück zum Zitat Nahata A, Dixit V. Ameliorative effects of stinging nettle (Urtica dioica) on testosterone‐induced prostatic hyperplasia in rats. Andrologia. 2012;44(s1):396–409.CrossRefPubMed Nahata A, Dixit V. Ameliorative effects of stinging nettle (Urtica dioica) on testosterone‐induced prostatic hyperplasia in rats. Andrologia. 2012;44(s1):396–409.CrossRefPubMed
29.
Zurück zum Zitat Harput US, Saracoglu I, Ogihara Y. Stimulation of lymphocyte proliferation and inhibition of nitric oxide production by aqueous Urtica dioica extract. Phytother Res. 2005;19(4):346–8.CrossRefPubMed Harput US, Saracoglu I, Ogihara Y. Stimulation of lymphocyte proliferation and inhibition of nitric oxide production by aqueous Urtica dioica extract. Phytother Res. 2005;19(4):346–8.CrossRefPubMed
30.
Zurück zum Zitat Yener Z, Celik I, Ilhan F, Bal R. Effects of Urtica dioica L. seed on lipid peroxidation, antioxidants and liver pathology in aflatoxin-induced tissue injury in rats. Food Chem Toxicol. 2009;47(2):418–24.CrossRefPubMed Yener Z, Celik I, Ilhan F, Bal R. Effects of Urtica dioica L. seed on lipid peroxidation, antioxidants and liver pathology in aflatoxin-induced tissue injury in rats. Food Chem Toxicol. 2009;47(2):418–24.CrossRefPubMed
31.
32.
Zurück zum Zitat Kao C, Hsieh C, Chen C, Liu C. The pharmacological effects of natural products and herbs in benign prostatic hyperplasia. Austin J Nutr Food Sci. 2014;2(10):1054. Kao C, Hsieh C, Chen C, Liu C. The pharmacological effects of natural products and herbs in benign prostatic hyperplasia. Austin J Nutr Food Sci. 2014;2(10):1054.
Metadaten
Titel
The Herbal Medicine Utrica Dioica Inhibits Proliferation of Colorectal Cancer Cell Line by Inducing Apoptosis and Arrest at the G2/M Phase
verfasst von
Ali Mohammadi
Behzad Mansoori
Mahyar Aghapour
Pooneh Chokhachi Baradaran
Neda Shajari
Sadaf Davudian
Shima Salehi
Behzad Baradaran
Publikationsdatum
19.04.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 2/2016
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-016-9819-3

Weitere Artikel der Ausgabe 2/2016

Journal of Gastrointestinal Cancer 2/2016 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.